Exclusive - EU decision on Russia's Sputnik V shot 'impossible' this year - source


FILE PHOTO: Doses of the Sputnik V vaccine against the coronavirus disease (COVID-19) are seen at a vaccination centre in Zilina, Slovakia June 7, 2021. REUTERS/Radovan Stoklasa

NEW YORK (Reuters): The EU drug regulator is unlikely to decide whether to approve Russia’s Sputnik V coronavirus vaccine until at least the first quarter of 2022 because some data needed for the review is still missing, a source with knowledge of the matter said.

“An EMA decision by the end of the year is now absolutely impossible,” the source said, referring to the European Medicines Agency.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

Floods, landslides kill 15 in India, four in Nepal as rivers rise
Men arrested in major incident at UK air base used by US
South Africa police hunt suspects after 27 killed in two separate shootings
Swiss vote on tightening neutrality rules, ending peacetime cooperation with NATO
Protesters block Catholic area in Northern Ireland ahead of Orange Order march
Northern Ireland court allows Protestant march in Catholic area, Sky News reports
Libya resumes crude pumping through Sharara-Zawiya pipeline after closure
Slovakia sees rapid expansion in electric vehicles, charging infrastructure
Russia says strikes destroyed 25 pct of Ukraine's internet, Starlink facilities
1st LD Writethru: Iran denies plans for military retaliation over recent air restrictions

Others Also Read